Carroll County TimesClinical trials and immunotherapy fuel optimism in cancer treatmentCarroll County TimesIt was early November 2015 when Helen Eyler, of Union Bridge, learned she had breast cancer. She turned to the William E. Kahlert Regional Cancer… Continue reading
KWTXSeeing hope: FDA panel considers gene therapy for blindnessKWTX(AP) Advisers to the U.S. Food and Drug Administration will meet Thursday to consider whether to recommend approval of a gene therapy aimed at improving vision for some people with here… Continue reading
OncLiveImmunotherapy Agents Leading Advancements in Metastatic Bladder CancerOncLiveThe therapeutic landscape is rapidly being altered by clinical trials of immunotherapy for patients with metastatic urothelial carcinoma (mUC), but simply changing the … Continue reading
OncLiveImmunotherapy Agents Leading Advancements in Metastatic Bladder CancerOncLiveThe therapeutic landscape is rapidly being altered by clinical trials of immunotherapy for patients with metastatic urothelial carcinoma (mUC), but simply changing the … Continue reading
OncLiveCAR T Cells Highly Successful in ALLOncLiveDefined composition chimeric antigen receptor (CAR) T cells directed against CD19 have potent anti-tumor activity in B cell malignancies, including acute lymphocytic leukemia (ALL). The experience with … Continue reading
Myeloma Research NewsFirst Myeloma Patient in Study Treated with New CAR T-Cell Therapy bb21217Myeloma Research NewsThe therapy belongs to the class of CAR T-cell therapies, where the immune T-cells are collected from a patient and then re-engineered i… Continue reading
Myeloma Research NewsFirst Myeloma Patient in Study Treated with New CAR T-Cell Therapy bb21217Myeloma Research NewsThe therapy belongs to the class of CAR T-cell therapies, where the immune T-cells are collected from a patient and then re-engineered i… Continue reading
|
International Stem Cell Corporation announces breakthrough with 3D bioprinted liver tissue
3ders.org (blog) LPCs, ISCO explains, can be created from “any kind of pluripotent stem cells,” such as human embryonic, induced pluripotent, or parthenogenetic stem cells using the organization’s novel (and proprietary) differentiation system. “I’m excited to announce … |